Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)

Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)
复制标题

DOI:
10.1016/j.jpain.2007.11.014
复制
发表时间:
2008-04-01
期刊:
影响因子:
4
通讯作者:
Jamison, Robert N.
Jamison, Robert N.
中科院分区:
医学2区
文献类型:
--
作者:
Butler, Stephen F.;Fernandez, Kathrine;Jamison, Robert N.

文献摘要

被引文献

相似文献

最初的疼痛患者筛选和阿片类药物评估(SOAPP)是一种概念上衍生的自我报告问卷,旨在预测考虑长期阿片类药物治疗的慢性疼痛患者的异常药物相关行为。本研究的目的是开发和验证SOAPP(SOAPP-R)的经验衍生版本,解决了原始SOAPP的一些局限性。在连续的步骤中,项目从最初的142项减少到97项测试版。测试版被用于283名接受长期阿片类药物治疗的慢性疼痛患者。根据随访时收集的数据,包括与异常药物行为指数(ADBI)的相关性,对项目进行评估,ADBI来自访谈数据、医生评级和尿液毒理学筛查。保留了24个项目,构成SOAPP-R的定稿。系数α为0.88,受试者工作特征曲线分析得出曲线下面积为0.81(P
The original Screener and Opioid Assessment for Patients with Pain (SOAPP) is a conceptually derived self-report questionnaire designed to predict aberrant medication-related behaviors among chronic pain patients considered for long-term opioid therapy. The purpose of this study was to develop and validate an empirically derived version of the SOAPP (SOAPP-R) that addresses some limitations of the original SOAPP. In successive steps, items were reduced from an initial pool of 142 to a 97-item beta version. The beta version was administered to 283 chronic pain patients receiving long-term opioid therapy. items were evaluated based on data collected at follow-up, including correlation with the Aberrant Drug Behavior Index (ADBI), derived from interview data, physician ratings, and urine toxicology screens. Twenty-four items were retained and comprise the final SOAPP-R. Coefficient alpha was.88, and receiver operating characteristics curve analysis yielded an area under the curve of .81 (P